Adial Pharmaceuticals, Inc.
ADIL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001513525
In the last 90 days, Adial Pharmaceuticals, Inc. insiders filed 2 open-market purchases and 0 sales; 17 institutions reported holding it in 13F filings for Q2 2026, worth $334.6K in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Adial Pharmaceuticals, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 23 | 26 | +3 |
| Shares | 3.17M | 1.70M | −1.47M (−46.5%) |
| Value | $6.38M | $2.27M | −$4.10M (−64.4%) |
New holders (7)
Institutions that held Adial Pharmaceuticals, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 39,490 | $53.0K | 0.00% |
| Truist Financial Corp | 33,862 | $45.0K | 0.00% |
| Virtu Financial LLC | 32,013 | $43.0K | 0.00% |
| Charles Schwab Investment Management Inc | 21,443 | $29.0K | 0.00% |
| StoneX Group Inc. | 15,000 | $20.1K | 0.00% |
| Jane Street Group, LLC | 13,854 | $19.0K | 0.00% |
| Simplex Trading, LLC | 7,723 | $10.0K | 0.00% |
Sold out (4)
Institutions that held Adial Pharmaceuticals, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Armistice Capital, LLC | 1,817,454 | $3.65M |
| Dimensional Fund Advisors LP | 31,410 | $63.0K |
| UBS Group AG | 6,840 | $14.0K |
| High Net Worth Advisory Group LLC | 1,000 | $2.00K |